SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MARCONI, Peggy Carla Raffaella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.314
EU - Europa 1.898
AS - Asia 960
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 2
OC - Oceania 1
Totale 10.185
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.310
CN - Cina 639
UA - Ucraina 502
IT - Italia 328
GB - Regno Unito 303
PL - Polonia 296
TR - Turchia 289
DE - Germania 217
FI - Finlandia 103
SE - Svezia 67
BE - Belgio 27
FR - Francia 23
VN - Vietnam 13
AT - Austria 10
IR - Iran 6
ES - Italia 5
BR - Brasile 4
NL - Olanda 4
CA - Canada 3
HK - Hong Kong 3
IE - Irlanda 3
IN - India 3
RU - Federazione Russa 3
CH - Svizzera 2
EU - Europa 2
IL - Israele 2
KR - Corea 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
CL - Cile 1
DK - Danimarca 1
EG - Egitto 1
ID - Indonesia 1
IQ - Iraq 1
JP - Giappone 1
LI - Liechtenstein 1
MA - Marocco 1
MX - Messico 1
NO - Norvegia 1
PE - Perù 1
VE - Venezuela 1
Totale 10.185
Salva come PNG Salva come JPEG
Città #
Fairfield 1.037
Woodbridge 1.028
Houston 589
Jacksonville 557
Chandler 495
Ashburn 465
Ann Arbor 436
Seattle 402
Wilmington 352
Cambridge 335
Warsaw 296
New York 227
Izmir 186
Nanjing 146
Ferrara 139
Beijing 135
Princeton 134
San Diego 105
Boardman 53
Shenyang 53
Shanghai 51
Milan 42
Hebei 37
Jiaxing 34
Tianjin 33
Nanchang 31
Brussels 27
Changsha 25
Falls Church 20
Los Angeles 19
Mountain View 18
Norwalk 18
Ningbo 15
San Mateo 15
Bologna 14
Jinan 14
Redwood City 14
Washington 14
Auburn Hills 13
Dong Ket 13
Orange 13
Kunming 12
Zhengzhou 11
Chicago 10
London 10
Vienna 10
Des Moines 9
Leawood 9
Modena 9
Taizhou 9
Ferrara di Monte Baldo 8
Verona 7
Augusta 6
Monmouth Junction 6
Guangzhou 5
Ardabil 4
Changchun 4
Hangzhou 4
Indiana 4
Philadelphia 4
Bari 3
Bremen 3
Dearborn 3
Dublin 3
Hounslow 3
Pieve Emanuele 3
Tappahannock 3
Toronto 3
Turin 3
Acton 2
Amsterdam 2
Anzola 2
Como 2
Custom House 2
Hong Kong 2
Kilburn 2
Lanzhou 2
Lappeenranta 2
Madrid 2
Munich 2
Napoli 2
Paris 2
Pegola 2
Pune 2
Redmond 2
Stienta 2
Stockholm 2
Trumbull 2
Valeggio sul Mincio 2
Wandsworth 2
Addison 1
Alcalá De Henares 1
Andover 1
Aprilia 1
Baghdad 1
Bergamo 1
Borgo Valsugana 1
Brookline 1
Brooklyn 1
Brugg 1
Totale 7.870
Salva come PNG Salva come JPEG
Nome #
Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors 188
null 179
Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection 161
Recombinant herpes simplex virus and uses therefor 152
Antitumor effects of non-replicative herpes simplex vectors expressing antiangiogenic proteins and thymidine kinase on Lewis lung carcinoma establishment and growth. 149
The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses. 145
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 135
Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures. 127
Herpes Simplex Virus Growth, Preparation, and Assay 125
HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma 124
CD40-signalling abrogates induction of RORγt+ Treg cells by intestinal CD103+ DCs and causes fatal colitis 122
Herpetic vectors inhibiting angiogenesis and inducing cell suicide in gliomas 120
Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer 119
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 117
Peripheral T Cells Re-Enter the Thymus and Interfere with Central Tolerance Induction 115
HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy 114
Parenchymal cells critically curtail cytotoxic T-cell responses by inducing Bim-mediated apoptosis 113
Identification of replication-competent HSV-1 Cgal(+) strain targets in a mouse model of human hepatocarcinoma xenograft 111
The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells 110
A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease 109
Localized overexpression of FGF-2 and BDNF in hippocampus reduces mossy fiber sprouting and spontaneous seizures up to 4 weeks after pilocarpine-induced status epilepticus 108
Modulation of mucosal and systemic immunity by enteric administration of nonreplicating herpes simplex virus expressing cytokines 107
Constitutive crosspresentation of tissue antigens by dendritic cells controls CD8(+) T cell tolerance in vivo 106
Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunity 106
MHC class I cross-presentation by dendritic cells counteracts viral immune evasion 105
null 104
Development and application of replication-incompetent HSV-1-based vectors 104
Protection from bacterial infection by a single vaccination with replication-deficient mutant herpes simplex virus type 1 104
Herpetic vectors inhibiting angiogenesis and Inducing cell suicide in gliomas 103
Gene transfer to muscle using herpes simplex virus-based vectors 102
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 102
Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice 101
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 101
HSV as a vector in vaccine development and gene therapy 100
Construction of Replication Defective Herpes Simplex Virus Vectors. 100
Transcriptional targeting of B cells for induction of peripheral CD8 T cell tolerance. 99
Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach 99
Development of Replication-Defective Herpes Simplex Virus Vectors 99
Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications 98
Purinergic Signaling: A New Pharmacological Target Against Viruses? 98
Botulinum neurotoxin light chains expressed by defective herpes simplex virus type-1 vectors cleave snare proteins and inhibit cgrp release in rat sensory neurons 98
Lentiviral-mediated transcriptional targeting of dendritic cells for induction of T cell tolerance in vivo 97
Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide 97
HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG35-55-induced experimental autoimmune encephalomyelitis in C57BL/6 mice 95
Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus model 95
High-efficacy thymidine kinase gene transfer to ovarian cancer cell lines mediated by herpes simplex virus type 1 vector 95
HSV as a vector in vaccine development and gene therapy 95
Engineering herpes simplex virus vectors for CNS applications 94
Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons 94
Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice 94
Herpesvirus-based vectors for gene transfer, gene therapy and the development of novel vaccines 93
Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis 93
Implications of maturation for viral gene delivery to skeletal muscle 93
Herpes Simplex Virus Type 1-Derived Recombinant and Amplicon Vectors 93
Replication-deficient mutant Herpes Simplex Virus-1 targets professional antigen presenting cells and induces efficient CD4+ T helper responses 92
Connexin 43-enhanced suicide gene therapy using herpesviral vectors 91
Gene transfer to muscle and spinal cord using herpes simplex virus-based vectors. 91
Progress in development of herpes simplex virus gene vectors for treatment of rheumatoid arthritis 90
Role of Herpes Simplex Envelope Glycoprotein B and Toll-Like Receptor 2 in Ocular Inflammation: An ex vivo Organotypic Rabbit Corneal Model 90
Replication-defective herpes simplex virus vectors for gene transfer in vivo 89
null 89
null 89
Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors 88
Rapid method for construction of recombinant HSV gene transfer vectors 87
Inhibition of HIV-1 replication by a Tat transdominant negative mutant in human peripheral blood lymphocytes from healthy donors and HIV-1-infected patients 86
null 84
Cytokine gene delivery into the central nervous system using intrathecally injected nonreplicative viral vectors 83
Herpes simplex virus type 1 (HSV-1)-derived recombinant vectors for gene transfer and gene therapy 82
Temporal lobe epilepsy model, neural stem cells and gene therapy 82
Virus erpetici come vettori vaccinali 82
null 81
Gene transfer into neurones for the molecular analysis of behaviour: focus on herpes simplex vectors 80
Capitolo 55 Retrovirus 79
Herpes simplex virus type 1 and Alzheimer’s disease: link and potential impact on treatment 79
Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severity 77
Strain specific maturation of Dendritic cells and production of IL-1β controls CD40-driven colitis 74
Advances in the development of herpes simplex virus-based gene transfer vectors for the nervous system 73
The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation 71
EFFECT OF TAT TRANSDOMINANT NEGATIVE MUTANTS ON HIV-1 REPLICATION IN JURKAT T-CELL LINES 69
Gene Therapy: a possible future option for multiple sclerosis 65
Herpes Simplex Virus Growth, Preparation, and Assay 64
Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes 63
Inhibition of HIV-1 replication and reactivation from latency by tat transdominant negative mutants in the cysteine rich region 63
Chapter 12:Unit 12.11. Construction of Replication-Defective Herpes Simplex Virus Vectors 62
Niosomes containing HSV immunogens as possible vaccine against genital herpes 62
Engineering herpes simplex virus vectors for human gene therapy. 61
Herpes Simplex Virus mediated gene transfer to neurons. 59
Poster: Herpes simplex vaccine vector co-expressing fused Mycobacterium Tuberculosis immunogens and Tat adjuvant enhances cellular and humoral responses in Balb/c mice 59
Herpes simplex virus vectors for gene transfer to the nervous system 59
Capitolo 44 Herpesviridae 58
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 58
Chapter 7 Gene Transfer to Muscle and Spinal Cord Using Herpes Simplex Virus-Based Vectors 56
The expression of immediate early genes of herpes simplex virus type 1 contributes to the neuroplasticity induced by viral infection on the enteric nervous system 56
In vivo transgene activation from an HSV-based gene therapy vector by GAL4:VP16 56
HIV-1 matrix protein p17 modulates in vivo preactivated murine T-cell response and enhances the induction of systemic and mucosal immunity against intranasally co-administered antigens 54
Molecular analysis of behavior by gene transfer into neurons with herpes simplex vectors 53
Chapter 8: Gene-transfer Tool: Herpes Simplex Virus Vectors 53
Herpes simplex gene therapy vectors for the treatment of cancer. 53
Virus vectors for immunoprophylaxis 52
Comunicazione orale, KN: A New Vaccine Approach To Fight Mycobacterium Tuberculosis 52
Totale 9.303
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.157
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.262
Totale 45.419
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019876 0 0 0 0 0 0 0 0 0 0 318 558
2019/20202.464 405 88 113 380 172 254 199 253 189 205 139 67
2020/20211.673 139 168 93 161 104 174 83 191 46 235 180 99
2021/20221.364 46 182 72 63 50 45 93 77 61 101 134 440
2022/20231.192 146 29 63 135 158 180 46 138 172 21 72 32
2023/2024684 79 84 42 26 39 264 55 43 21 25 6 0
Totale 10.362